Thursday, 27 April 2017

Cordura to Exhibit Its New Military Fabrics at IDEX 2017

There is growing requirement of advanced warfare technology due to increasing terrorist activities and tensions between various countries, which also propels demand for ballistic protection products like bullet proof vests, headgear, armored car, shields, missiles, and eyewear.

Cordura’s Latest Innovations:

A new brand of Invista—“Cordura”—will be showcasing its new fabric innovations for military gear and apparel at IDEX 2017. The wide array of these latest hardwearing and flexible soldier systems fabric technologies on display will comprise lightweight comfort Cordura Nyco Tactical uniform fabrics and Flame Retardant (FR)-coated polyamides for protective vests and Solution Dyed Nylon (SDN) with built-in Near Infrared (NIR)/ Short-Wave Infrared (SWIR) reflectance capabilities,

SDN Technologies:

The SDN solutions are suitable for load carriage equipment, knee/elbow pads, body armor covers, boots, and various other similar tactical gears. These textiles are available in a palette of six military colors that meet both infrared and lot-to-lot shade requirements. Moreover, they have fixed NIR/SWIR reflectance ability and high resistance to strength degradation & sunlight UV fade.

Invista T420HT Fibre:

New T420HT is a high-tech, patent-pending Cordura brand-qualifying “Invista T420HT staple fiber” with excellent persistence. Designed to help improve the core strength of materials and particularly suitable in lighter weight constructions, this fiber technology is the best nylon 6,6 staple fiber ever created by Invista.

FR-Coated Polyamides:

The latest FR-covered Cordura nylon 6,6 materials are engineered to be the first line of defense of the soldiers in ballistic/protective vests. It can provide protection from flame, thermal propagation, and heat (in case of protective footwear & apparels).

Cordura Nyco Tactical Uniform Fabrics:

This optimized textile is a comfort blend of cotton & Invista T420 fiber. It is designed to provide safety & security to warfighters and their essential equipment through exceptional durability & lighter weight.

Market Insights:

The global ballistic protective equipment market is expected to grow rapidly over the forecast period (from 2014 to 2025). The market for ballistic protective equipment is expected to reach USD 5.7 billion by 2025, as per a report published by Grand View Research Inc. Some of the major players in the industry include The E. I. du Pont de Nemours and Company; Toyobo Co.; and Honeywell International, Inc.

In-depth report on ballistic protective equipment market by Grand View Research:

Monday, 24 April 2017

Polymer Chameleons Find New Applications as Research Programs Rise!

Polymer chameleons, also called as environmentally-sensitive polymers or smart polymers, are stimuli-responsive polymers that go through speedy amendments in their microstructure, caused by various environmental changes. These polymers are poised for rapid commercialization & adoption across the industries, particularly, healthcare. The increasing usage of bioengineered polymeric products that provide high efficiency and high strength to produce modern hi-tech, end-user materials is likely to augment the market demands during the forecast period (from 2014 to 2025).

Recent Application Discoveries for Smart Polymers:

Despite some challenges, research programs & collaborations between the industry and the R&D community as well as financial support from both governments & private companies are helping in the industry develop. Extensive research on the possible applications of polymer chameleon in various fields, such as pharmaceuticals, implants, molecular separation, flexible chips, drug delivery, biofilms, etc., is in progress.

Growing importance of smart materials with better lifespan is driving the usage of polymer chameleons in different industries, such as healthcare. Research programs for smart polymers in drug delivery products for particular applications are ongoing in the healthcare industry. They are already executing and also looking to expand into several other product sectors and industries, such as personal care.

Challenges Faced by Technology Developers:

Customization of these polymers as per end-use applications, scalability, and cost-effective production are the major issues faced by the technology developers. High raw material prices are another restraint to commercialization and large-scale uptake.

However, research and strategic collaborations are allowing the stakeholders increase the scope of these polymers. Designing technology specific to a particular end application is the best way for a firm to manage an R&D portfolio.

Market Overview:

The usage of advanced technologies to create superior products is said to positively affect the growth of the global market. Factors such as strict execution of rules by various governing bodies, increased disposable income levels, and high demand for light-weight & low-fuel combustion automobiles have augmented the demands for engineered polymeric products. The global polymer chameleons market is projected to reach USD 1.6 billion by 2025, as per to a report published by Grand View Research, Inc. Some major companies operating in the global polymer chameleons market are Autonomic Materials, Inc.; Evonik Industries AG; E. I. du Pont de Nemours and Company; BASF SE; and Akzo Nobel N.V.

Read more at:

Thursday, 20 April 2017

High Folic Acid Intake Can Lower Chances of Aneuploidy

Aneuploidy refers to abnormal number of chromosomes in a cell and results in genetic disorders such as Down’s and Edward’s syndromes. Aneuploidy is associated with deficiency of folate in the human body. Folate is the term for naturally occurring group of water soluble b vitamins. Folic acid is the synthetic version used in food fortification and dietary supplements. It is most commonly recommended for pregnant women to help prevent Neural Tube Defects (NTDs) in newborn babies. The natural sources of folate are leafy vegetables, fruits, okra, asparagus, tomato juice, and orange juice.

Folic acid supplements have also been reported as effective in treating cardiovascular disorders, cancer, and psychiatric illnesses. Newborn babies require around 65 micrograms (mcg) of folate, while pregnant women need at least 600 mcg daily. Hispanic and Latina women are recommended to follow a folate-rich diet due to low folate levels in their blood. Use of tobacco, alcohol or caffeine also affects folate levels in the body, especially in men.


Male Fertility

According to a recent study by the National Health Service (NHS) in the UK on effects of folic acid, men with low levels of this vitamin suffer from low sperm count. For every 100 gram increase of daily folate intake, there was a 3.6% reduction in the chance of chromosomal abnormality.

Hair Growth

Deficiency in folic acid can result in alopecia or hair loss. Hair discoloration occurs on account of megaloblastic anemia—a condition in which abnormally large red blood cells are produced and the total red blood cell count is low. Regular consumption of folic acid can restore hair. A study by the Ontario Veterinary College in Canada demonstrated hair restoration in Charolais calf.

Risk of Excessive Intake:-

While the cases of NTDs in the United States have reduced, it has been found that excessive intake of folic acid can increase the risk for cancer. For instance, postimplementation of folic acid fortification programs in Canada and U.S., an increase in incidence of colorectal cancer has been noticed. High intake of folate can result in deficiency of vitamin B12 among the geriatric populace. Thus, the upper limit for daily intake in male and female adults should not cross 1,000 mcg.

Market Overview:-

The worldwide folic acid market is anticipated to grow at a CAGR of 3.5% from 2016 to 2025; according to Grand View Research, Inc. Demand of folic acid tablets by pregnant women can spur market growth.

Pharmaceuticals were the largest market application in 2015. This can be attributed to the extensive demand of folic acid in tabular form to treat cardiovascular and urinary disorders. Asia Pacific led the global market in 2015 due to abundant supply of raw materials from China. Regions within APAC, such as Pakistan and Bangladesh, have introduced folic acid fortification in wheat and oil. This can help fight anemia. Some major market players are Emcure Pharmaceuticals Ltd.; Zydus Pharmaceuticals Ltd.; and BASF SE.

In-depth report on global folic acid market by Grand View Research:

Tuesday, 18 April 2017

Anaphylaxis Treatment Becomes Easy With Prefilled Syringes

Syringes are needed by doctors to successfully administer various medications to patients. The limited production of conventional syringes and their reuse by healthcare practitioners leading to cross-infections gave birth to prefilled syringes. Conventional syringes are even used by drug addicts to inject themselves intravenously. 

Prefilled syringes come in predetermined doses or quantities. Some of these devices have an added self-locking mechanism that kicks in after one use, which prevents their reuse and protects others from possible infections. These syringes are currently in high demand due to the high incidence of diabetes and Rheumatoid Arthritis (RA). Silicone oil is used as a lubricant in the syringes to enhance their shelf life.

Novel Developments

Scandinavian Health Limited (SHL) Group, a Swedish manufacturer of autoinjectors and prefilled syringes, launched two major products targeting RA patients: “Amber Auto Injector”—a device with customized shapes for gripping the injector—which would aid RA patients with severe dexterity issues and “Emerade Auto Injector”—a two-step disposable syringe—which can administer doses in three strength levels– 150, 300, and 500 micrograms (mcg). It can be used to administer adrenaline in case of anaphylaxis or emergency. It has reportedly the longest needle in the market.

The company has also released an autoinjector (“Molly C”) with an inbuilt data recording system dubbed “Recording Unit.” This system allows the device to save patient-related data successfully from their smartphone. It allows users to post their query on Alubena—a common platform to solve drug-delivery issues related to the product.

Market Overview

The worldwide prefilled syringes market size is expected at USD 22.5 billion by 2025. It is driven by the increasing global use of prefilled syringes and technological breakthroughs in autoinjectors.

Glass prefilled syringes dominated the global market in 2015, but plastic syringes segment is anticipated to reign from 2016 to 2025 (forecast period). Diabetes is predicted to be the largest market application throughout the forecast period. Owing to technological advancements, North America is expected to exhibit high growth over the forecast period. Some key industry players are Scandinavian Health Limited (SHL Group), Schott AG, and Unilife Corporation.

Monday, 10 April 2017

Fundus Camera: Revolutionizing Eye Care

Fundus cameras help in early detection and monitoring of chronic eye diseases such as Diabetic Retinopathy (DR), cataract, glaucoma, among others. These cameras are used to capture images of the fundus or the back of the eye. They are equipped with intricate microscopes enabling the photography of optic disc, retina, and macula. 

Advanced Technology

The Hybrid Kowa VX-20 offers high quality, versatile, retinal imaging. The improved functionalities of this device include a-touch-of-a-button solution, which allows the operator to easily switch between non-mydriatic and mydriatic mode. Such devices are equipped with an easy-to-use wide color LCD touch screen that facilitates easy patient observation. Such devices enable simple singled-handed operation. 

VX-20 has superior quality retinal imaging with several photography modes: Fundus Auto Fluorescence (FAF), Red-Free (RF), mydriatic color, non-mydriatic color, Fluorescein Angiography (FA), small pupil , and anterior. Stable chassis facilitate easier patient alignment and LED eye level mark makes eye testing in a darkroom convenient.

These devices enable saving of the captured images on a compact flash memory card and the images can be directly printed. They are also equipped with instant image filing software. The VX-20 offers mydriatic and FA modes with 50° and 30° views and non-mydriatic with 45° and 27°. Moreover, it has an FAF mode that further assists in the diagnostic investigation of retinal health and detection of Age-related Macular Degeneration (AMD). 

The machine is linked to VK-2 software to provide outstanding fundus images. Photographic settings can be adjusted using simple operations, which makes these devices patient friendly. In the mydriatic color, FAF, RF, and FA modes, photography under monitor observation can reduce a patient’s photophobia. The capture mode enables users put in IDs and display the alignment of captured images. 

Market Overview

According to a new report by Grand View Research Inc., the global fundus camera market is predicted at USD 625 million by 2024. Increasing prevalence of glaucoma, DR, and AMD is anticipated to drive the market. 

Key Players

Some of the key players in the market are Topcon Medical Systems, Inc.; Canon, Inc.; NIDEK Co., Ltd.; and Optomed Oy Ltd. They adopt various strategies to sustain in the market: participate in launching of new products, expansion of global sales network, develop strategic partnerships, and invest in research & development.

Thursday, 6 April 2017

Secure Logistics: Safeguarding Finances

Rapid technological advancements in banking and corporate industries have increased their susceptibility to crime, which has increased the need to safeguard, manage, and transport currency. Security is now extended to various industries associated with cash management, manufacturing, diamonds, jewelry & precious metals, etc. Cash management involves cash-in-transit, cash processing, and Automated Teller Machines (ATMs). 

Cardless ATM

Diebold is an American self-service, security, and services corporation that develops ATMs with advanced technology. They have developed an ATM machine called “Irving” that does not require a physical card. It authorizes withdrawal transactions using Smartphone and iris-scan biometric technology. 

Irving eliminates the need for pin pad, screen on the machine, and a card reader. The omission of these parts results in a much smaller ATM machine. In order to withdraw cash, a user needs to connect his/her smartphone to the machine using Near Field Communication (NFC) or a secure wireless technology. The machine uses an iris scan to authenticate the identity of the person withdrawing the amount. Cash is dispensed “only” after the identity of a user is confirmed. The whole process requires about 10 seconds. This techology is being tested by Citigroup at their bank’s innovations laboratory in New York.

Diebold is also working on a second machine “Janus,” which could substitute a teller in a bank. Janus shares alarm boards, monitoring technology, and connectivity. The machine provides terminals to serve two customers at a time, without compromising the speed and security of a transition. It also includes a touch screen for a more advanced account access and a video teller to help them with complex transactions. Most importantly, it is very user friendly. 

Janus is also mobile enabled thru NFC or Quick Response (QR) code. The machine eliminates the threat of card frauds and the use of traditional card readers. Printed receipts have been replaced by text and email receipts. It is equipped with an interactive touch screen that enables multiple check imaging and ID scanning for document signing and new account creation. The terminals include privacy panels with an intuitively integrated screen. It also has a single-shot cash interface with a more refined modern design. 

Market Overview

The global secure logistics market is anticipated to surpass USD 109 billion by 2025, according to a new report by Grand View Research, Inc. ATMs play an integral role in maintaining core banking touch points with consumers. This is expected to drive the secure logistics market over the coming years.

Market Rivals

Brink’s, Cargo Guard Secure Logistics, G4S Secure Solution, and CMS Infosystem Pvt. Ltd., are some of the major competitors of this market. They undertake mergers and acquisitions in order to enhance their product portfolios and expand their global presence.

Monday, 3 April 2017

Revitalize Your Heart With Cardiac Resynchronization Therapy

Heart-related diseases have become extremely common due to the hectic lifestyle led by people. Some people are diagnosed with arrhythmia, an irregular heartbeat that can prove fatal. More than 2 million people in the U.S. reportedly suffer from Atrial Fibrillation (AF), a type of arrhythmia, and the geriatric populace is highly susceptible to the same. 

Cardiac Resynchronization Therapy (CRT) is a device designed to treat heart failure. It sends electrical impulses to the lower chambers of heart, which facilitates synchronized heart beats. CRT-P (CRT-pacemaker) and CRT-D (CRT-defibrillator) are two types of implantable cardioverter defibrillators (ICDs) that aid in treating heart failure. A CRT-D device can treat arrhythmia by delivering shock to the heart, while a CRT-P device does the same when it beats at an abnormally slow rate.

Novel Developments

EBR Systems, Inc., an American manufacturer of cardiac implants, has received U.S. FDA approval for the “Wireless Stimulation Endocardially” (WiSE) technology to reduce the dependency on lead pacemakers to treat heart failure. It boasts of being the world’s only wireless pacemaker that stimulates the endocardium of the left ventricle. It has been reported that a significant percentage of consumers responded positively to this therapy. WiSE is expected to benefit nearly 1.5 million patients globally.

In 2016, Medtronic Plc received approval from U.S. FDA for its proprietary product “Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D) SureScan.” Medtronic’s EffectivCRT Diagnostic, which automatically estimates the strength of each left ventricular pace, is a component of Claria. Claria automatically adjusts pacing rates during AF, without adversely impacting the average heart rate. This device is designed to run in 1.5 and 3 Tesla Magnetic Resonance Imaging (MRI) machines.

Market Outlook

The global cardiac resynchronization therapy (CRT) market is anticipated to reach USD 8 billion by 2025. The rising cases of heart failure worldwide are expected to spur market demand from 2014 to 2025 (forecast period).

The Sudden Cardiac Arrest Foundation has estimated that nearly 6 million suffer from cardiac disorders. This is anticipated to spur market growth in order to minimize hospital costs. CRT-D devices are anticipated to dominate the market over the forecast period.

North America accounted for over 30% of the market share in 2015 due to the growing regional geriatric population. Latin America and Asia Pacific are expected to contribute over 30% to global revenue by 2025. Some of the prominent market players are Boston Scientific Corporation, LivaNova Plc., and Medtronic Plc. 

In-depth report on global cardiac resynchronization therapy (CRT) market by Grand View Research: